Posted On: 09/30/2014 8:49:06 PM
Post# of 273350
Abbott Laboratories (ABT) 41.59 $ABT
Next Support Level for Abbott Laboratories (ABT) is $41.52
Comtex SmarTrend(R) - Tue Sep 30, 1:00PM CDT
Abbott Laboratories (NYSE:ABT) has opened bearishly below the pivot of $41.86 today and has reached the first level of support at $41.71. Analysts will be watching for a cross of the next downside pivot targets of $41.52 and $41.19.
Global Home Healthcare Market 2014 - 2020: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices & Mobility Assist Devices and Medical Supplies
M2 - Tue Sep 30, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thxb6j/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market is estimated to be USD 176,107.9 million in 2013 and is expected to reach USD 303,605.9 million by 2020, growing at a CAGR of 8.1% from 2014 to 2020 Increasing sedentary lifestyle and aging population globally would surge the demand of home healthcare devices and services market. However, accuracy and limited geographic presence of service providers are some of the factors that restrict the growth of this market. For example, home healthcare service providers like The Linde Group and Gentiva Health Services, Inc. has limited market geographic presence in economies like Asia-Pacific, Russia and Latin America. The market of global home healthcare market is categorized as device types and services. Home healthcare devices market is segmented as diagnostics and monitoring home healthcare devices, therapeutics home healthcare devices, mobility assist devices and medical supplies. The market for diagnostics and monitoring devices segment accounted for the largest share owing to rising prevalence of chronic diseases coupled with increasing healthcare awareness. However, therapeutics home healthcare devices segment is expected to grow at the highest CAGR of over 10% from 2014 to 2020. Introduction of advanced and easy to use therapeutics home healthcare devices will help this segment to record highest CAGR. Services segment in the global home healthcare market accounted for the largest share in 2013. This dominance was majorly due to the presence of large number of home healthcare service providers and strong acquisition strategies of these healthcare service providers. The Global home healthcare market is segmented as follows: Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/th...lobal_home
3 Reasons AbbVie Inc Stock Could Fall
Keith Speights, The Motley Fool - Motley Fool - Fri Sep 26, 9:17AM CDT
Back in early 2013, there was considerable speculation about how Abbott Laboratories' then-new spin-off AbbVie would fare on its own. That speculation was answered by AbbVie's stock performance. Shares have surged around 65% since then....
Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares
PR Newswire Europe - Fri Sep 26, 8:00AM CDT
--Acquisition enhances Abbott's position in Latin America, more than doubling its branded generics pharmaceutical sales and presence in the fast-growing region
Health Care Equipment Equities under the Scanner - Medtronic, Abbott Laboratories, Stryker, Zeltiq Aesthetics, and EnteroMedics
PR Newswire - Fri Sep 26, 7:40AM CDT
On Thursday, September 25, 2014, the NASDAQ Composite ended at 4,466.75, down 1.94%, the Dow Jones Industrial Average finished the day 1.54% lower at 16,945.80, and the S&P 500 closed at 1,965.99, down 1.62%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 743.47, down 1.58%, while the index has advanced 1.48% in the last one month. Investor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Stryker Corporation (NYSE: SYK), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), and EnteroMedics Inc. (NASDAQ: ETRM). Free research on these five companies can be accessed at:
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King Worldwide
PR Newswire - Thu Sep 25, 9:04AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic, Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Abbott Laboratories (NYSE:ABT-Free Report), Mylan, Inc. (Nasdaq:MYL-Free Report) and Burger King Worldwide, Inc. (NYSE:BKW-Free Report).
Ex-CEO charged in ballplayer's insider trade
AP - Wed Sep 24, 10:03PM CDT
SANTA ANA, Calif. (AP) — Federal prosecutors say the former CEO of a Southern California medical device company has been indicted on allegations that he shared insider trading secrets with former Baltimore Orioles All-Star Doug DeCinces.
Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Sep 24, 9:22AM CDT
Late on Monday, the U.S. Treasury Department outlined new rules to deter domestic companies from moving abroad in an attempt to reduce tax payments.
Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.
PR Newswire - Wed Sep 24, 8:00AM CDT
Abbott today announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation, and for the purchase from all holders, wherever resident, of CFR's outstanding American Depositary Shares. The offer was not conditioned on the receipt of any minimum number of ordinary shares or American Depositary Shares being tendered.
Medical Diagnostic Devices Research Digest - H1 2014: Latest News for Medical Devices, In-Vitro Diagnostic Devices & Medical Imaging Devices
M2 - Wed Sep 24, 6:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnbznw/medical) has announced the addition of the "Medical Diagnostic Devices Research Digest - H1 2014" subscription to their offering. The Medical Diagnostic Devices Research Digest is a round-up of all the most important research in the industry each quarter available as an annual subscription, gathered from over 50 sources including associations, market intelligence companies, Journals, company news articles , consultants and industry participants. Updated quarterly, the Digest allows you to: - Quickly update yourself on the latest research findings, gathered and organised for you. - Get our Expert Analysts' perspectives on the latest research. - Link through to the original research to review or purchase. Key Topics Covered: 1 Global Medical Devices Research - Medical Devices M&A Value Falls by Over Half in 2013 Against 2012 - Global Medical Devices Market Showing Only Moderate Growth - Big Fall In Regulatory Approvals of Medical Devices - Top 10 Medical Device Companies 2013 - Cyber-Attacks on Medical Devices Endanger Patients' Lives - US Medical Device Manufacturers Paid $1bn in Excise Tax In 2013 - Strategic Rationale of Medtronic-Covidien Deal - Manufacturing Costs Of Medical Devices Significantly Lower Outside The U.S. - New Trends in Private Healthcare Service Providers in APAC, But Hospitals Remain the Major Providers - China's Healthcare Reform Continues to Drive Its Medical Devices Market 2 In Vitro Diagnostic Devices Research - Global In Vitro Diagnostic (IVD) Devices Market Moderate Growth - Johnson & Johnson Divests Its IVD Business - Becton Dickinson Leads Global Flow Cytometry Market - Clinical Chemistry And Coagulation Tests Dominate North America IVD Market - Cost Of Cholesterol Tests Vary Widely Across The U.S. - Molecular Diagnostics' Rapid Growth In The U.S. IVD Market - U.S. Companion Diagnostics Significant Growth - Hospital-Acquired Infections (HAI) Drive The U.S. Infectious Diseases Testing Market - U.S. IVD Market, Competitive Landscape 2013 - New Entrants Gain Share In The U.S. Blood Testing Market - European Companion Diagnostics' Remarkable Growth - European Law Restricts German IVD Market Growth - French IVD Market Restraints - French Government Strengthens Transparency In Healthcare Sector - Public Healthcare Budget Impacts On Italian IVD Market - Spanish IVD Market Declines Substantially - Nail Test For Bone Quality Launched In The UK - Taxes In Brazil Suppress IVD Market Growth - Brazilian IVD Manufacturers Gain Momentum - Rapid Growth Forecast For Chinese Digital Pathology Market - Public-Private Partnerships Drives Indian IVD Market - Indian IVD Market - Competitive Landscape - Indian Clinical Laboratories Still Use Manual Methods 3 Medical Imaging Devices Research - Diagnostic Ultrasound Market In Developed Economies Depends On Replacement Of Already Installed Systems - Film-Screen Mammography (FSM) Systems Usage Phased Out In Europe - Adoption Of Breast Tomosynthesis System Faster In Europe Than The U.S. - Prices Of CT And MRI Scan Vary Widely Across The U.S. - Medical Imaging Contribution To Washington State's Economy - Mammography Reduces U.S. Mortality Rate - Canadian Initiative Controls Overutilization Of Lumbar MRI Scans - China's Diagnostic X-Ray Imaging Market Sees Rapid Growth Companies Mentioned - Abbott - Abbott Laboratories - Agappe Diagnostics - Arkray - Beckman Coulter Inc. and Becton Dickinson - Bio-Rad and Danaher - CPC Diagnostics - Crescent Diagnostics - DASA Diagnostic Laboratory Group - EMD Millipore - GrupoFleury and Hermes Pardini - Hologic - Hologic - iCyt Sysmex - Johnson and Johnson - LabCorp - Lilac Medicare - Merck - Mindray - Ortho-Clinical Diagnostics - Partec - Qiagen - Quest Diagnostics - Roche Diagnostics - Siemens Healthcare - Sony Technology - Theranosis - Thermo fisher and Alere - Transasia Bio-Medicals - Tulip and Bhat-Biotech For more information visit http://www.researchandmarkets.com/research/rnbznw/medical
New Developments in the Companion Diagnostics Market 2014
M2 - Wed Sep 24, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zlp33x/companion) has announced the addition of the "Companion Diagnostics Market" report to their offering. There had been a slow market uptake of companion diagnostics because companion tests lacked FDA approval, which prevented pharmaceutical companies from promoting the diagnostic. But the realization that companion diagnostics can decrease costs by identifying the patient population that will most likely benefit from a therapy and ruling out those therapies not likely to be effective has made companion diagnostics important to the delivery of care. This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information: Cancer Cardiovascular and Blood Metabolic Infection Neurological Market Size by Disease Area, 2013 and 2018Companion diagnostics have met with considerable challenges in penetrating the market, but are now rising to the forefront of pharmaceutical development and treatment, increasing the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. Companion diagnostics and biomarkers provide insight into understanding disease processes and ways that medicines can work to counteract the disease. The majority of competitive participation for companion diagnostics is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. There are numerous companies in the market which include large multiproduct companies such as Roche and Abbott and small niche developers such as 20/20 GeneSystems. Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION TO THE COMPANION DIAGNOSTICS INDUSTRY THREE: INDUSTRY TRENDS FOUR: COMPANION DIAGNOSTIC PRODUCTS FIVE: MARKET SIZE AND GROWTH SIX: COMPANY PROFILES - 20/20 Genesystems, Inc. - Abbott Laboratories - Affymetrix - Asuragen, Inc. - Beckman Coulter, Inc - Becton, Dickinson - Biocartis S.A. - Biodesix, Inc. - Biomerieux Sa - Bioreference Laboratories, Inc - Biotheranostics, Inc. - Cardiodx, Inc - Celera Alameda - Clarient, Inc - Decode Genetics, Inc. - Diagenic Asa - Genomic Health, Inc. - Genoptix Medical Laboratory - Illumina, Inc. - Johnson & Johnson - Life Technologies Corporation (Part Of Thermo Fisher) - Myriad Genetics, Inc. - Nanostring Technologies, Inc. - Opko Health, Inc. - Provista Dx - Qiagen N.V. - Roche - Siemens Healthcare - Singulex, Inc - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/zlp33x/companion
After Yesterday's Decline of 2.09%, Abbott Laboratories Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 23, 3:53PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $42.49 to a high of $43.16. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $43.22 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Abbott Laboratories Shares Up 10.8% Since SmarTrend's Buy Recommendation (ABT)
Comtex SmarTrend(R) - Tue Sep 23, 9:46AM CDT
SmarTrend identified an Uptrend for Abbott Laboratories (NYSE:ABT) on April 22nd, 2014 at $38.75. In approximately 5 months, Abbott Laboratories has returned 10.83% as of today's recent price of $42.94.
Research and Markets: China POCT Market 2014-2018: Abbott Laboratories, Bayer HealthCare, F. Hoffmann-La Roche & LifeScan Dominates the Market
Business Wire - Tue Sep 23, 3:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r3shd9/poct_market_in) has announced the addition of the "POCT Market in China 2014-2018" report to their offering.
China POCT Market 2014-2018: Abbott Laboratories, Bayer HealthCare, F. Hoffmann-La Roche & LifeScan Dominates the Market
M2 - Tue Sep 23, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gch85q/poct_market_in) has announced the addition of the "POCT Market in China 2014-2018" report to their offering. The POCT market in China to grow at a CAGR of 20.69% over the period 2013-2018 POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. The expanding economy of China is one of the major trends witnessed in this market. The Government of China is making efforts to improve healthcare infrastructures, which has benefited the POCT market. According to the report, one of the major drivers in the market is the increase in innovations in technology to provide efficient and inexpensive devices to diagnose and treat diseases. Advances in technology and innovations in the Healthcare industry have resulted in the development of equipment with technology that is customized as per the needs of the patient. Further, the report states that one of the major challenges in the market is the advances in technology. The entry of new technology in the market forces the frequent elimination of the POCT products of the large vendors. To calculate the market size, the report considers the revenue generated through the following applications of POCT: - Blood glucose testing - Cholesterol testing - Infectious disease testing - Blood gas testing - Cardiac biomarkers testing - Pregnancy testing - Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing) Key Vendors - Abbott Laboratories - Bayer HealthCare - F. Hoffmann-La Roche - LifeScan Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Market Segmentation by Technology - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/gc..._market_in
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 5:20PM CDT
Novo Nordisk (NVO) announced data from new analyses of the phase IIIa DUAL I and DUAL II studies on Xultophy.
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 3:45PM CDT
Novartis (NVS) announced that positive data on its pipeline candidate, LBH589 (panobinostat), was published in The Lancet Oncology.
Research and Markets: Global PCR Technologies Global Market 2014-2020
Business Wire - Mon Sep 22, 3:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rb5tts/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering.
Global PCR Technologies Global Market 2014-2020
M2 - Mon Sep 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4kvrrv/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering. Some of the key players in the PCR market are Abbott Laboratories, Affymetrix, inc., Takara bio, Agilent Technologies, Beckman Coulter Inc., Quanta biosciences, Bio-Rad, Becton, Dickinson and Co., GE Healthcare, Sigma-Aldrich Corp., and Roche. Polymerase chain reaction (PCR) is a gene amplification technique that amplifies a single or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence. PCR plays a crucial role in understanding the genetic diseases and is also used in the characterization and detection of infectious disease organisms in diseases like Lyme disease, AIDS, middle ear infection and tuberculosis. PCR is an indispensable technique in Biotechnology, drug discovery and clinical diagnostics and it's key applications include DNA sequencing, Forensic science, Genotyping, Bioinformatics, gene expression, genetic mapping and DNA cloning. PCR products market includes Reagents, consumables, instruments, software and services. Some of the key techniques available in market are Standard/basic PCR, Real-time/Q-PCR, Digital PCR (dPCR), Reverse transcriptase PCR, Assembly PCR, Inverse PCR, Nested PCR, Multiplex PCR, Hot start PCR and touchdown PCR Among the various techniques, Q-PCR appears to be the fastest growing in PCR market followed by Reverse-Transcription PCR (RT-PCR) and Assembly. Based on the classification by products/tools, PCR Reagents is expected to be fastest growing PCR market followed by PCR Consumables and Machines. The global PCR market is projected to grow at a healthy rate. North America would account for the largest market share followed by Europe and Asia-pacific. Increasing number of patients suffering from Infectious diseases, Cancers and positive investments in gene therapy and human genome project are further driving the growth of the PCR market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 PCR Market by Types 5 PCR Market by Application 6 PCR Market by Technology 7 Regional Market Analysis 8 Company Developments 9 Major Company Profiles - Abbott Laboratories - Becton, Dickinson And Co. - Bio-Rad - Ge Healthcare - Kapa Biosystems - Maxim Biotech - Promega Corp. - Quanta Biosciences Inc. - Roche - Sigma-Aldrich Corp. - Takara Bio - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/4k...chnologies
Next Support Level for Abbott Laboratories (ABT) is $41.52
Comtex SmarTrend(R) - Tue Sep 30, 1:00PM CDT
Abbott Laboratories (NYSE:ABT) has opened bearishly below the pivot of $41.86 today and has reached the first level of support at $41.71. Analysts will be watching for a cross of the next downside pivot targets of $41.52 and $41.19.
Global Home Healthcare Market 2014 - 2020: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices & Mobility Assist Devices and Medical Supplies
M2 - Tue Sep 30, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thxb6j/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market is estimated to be USD 176,107.9 million in 2013 and is expected to reach USD 303,605.9 million by 2020, growing at a CAGR of 8.1% from 2014 to 2020 Increasing sedentary lifestyle and aging population globally would surge the demand of home healthcare devices and services market. However, accuracy and limited geographic presence of service providers are some of the factors that restrict the growth of this market. For example, home healthcare service providers like The Linde Group and Gentiva Health Services, Inc. has limited market geographic presence in economies like Asia-Pacific, Russia and Latin America. The market of global home healthcare market is categorized as device types and services. Home healthcare devices market is segmented as diagnostics and monitoring home healthcare devices, therapeutics home healthcare devices, mobility assist devices and medical supplies. The market for diagnostics and monitoring devices segment accounted for the largest share owing to rising prevalence of chronic diseases coupled with increasing healthcare awareness. However, therapeutics home healthcare devices segment is expected to grow at the highest CAGR of over 10% from 2014 to 2020. Introduction of advanced and easy to use therapeutics home healthcare devices will help this segment to record highest CAGR. Services segment in the global home healthcare market accounted for the largest share in 2013. This dominance was majorly due to the presence of large number of home healthcare service providers and strong acquisition strategies of these healthcare service providers. The Global home healthcare market is segmented as follows: Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/th...lobal_home
3 Reasons AbbVie Inc Stock Could Fall
Keith Speights, The Motley Fool - Motley Fool - Fri Sep 26, 9:17AM CDT
Back in early 2013, there was considerable speculation about how Abbott Laboratories' then-new spin-off AbbVie would fare on its own. That speculation was answered by AbbVie's stock performance. Shares have surged around 65% since then....
Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares
PR Newswire Europe - Fri Sep 26, 8:00AM CDT
--Acquisition enhances Abbott's position in Latin America, more than doubling its branded generics pharmaceutical sales and presence in the fast-growing region
Health Care Equipment Equities under the Scanner - Medtronic, Abbott Laboratories, Stryker, Zeltiq Aesthetics, and EnteroMedics
PR Newswire - Fri Sep 26, 7:40AM CDT
On Thursday, September 25, 2014, the NASDAQ Composite ended at 4,466.75, down 1.94%, the Dow Jones Industrial Average finished the day 1.54% lower at 16,945.80, and the S&P 500 closed at 1,965.99, down 1.62%. The losses were broad based as all the ten sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 743.47, down 1.58%, while the index has advanced 1.48% in the last one month. Investor-Edge has initiated coverage on the following equities: Medtronic Inc. (NYSE: MDT), Abbott Laboratories (NYSE: ABT), Stryker Corporation (NYSE: SYK), Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ), and EnteroMedics Inc. (NASDAQ: ETRM). Free research on these five companies can be accessed at:
The Zacks Analyst Blog Highlights: Medtronic, Covidien, Abbott Laboratories, Mylan and Burger King Worldwide
PR Newswire - Thu Sep 25, 9:04AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Medtronic, Inc. (NYSE:MDT-Free Report), Covidien plc (NYSE:COV-Free Report), Abbott Laboratories (NYSE:ABT-Free Report), Mylan, Inc. (Nasdaq:MYL-Free Report) and Burger King Worldwide, Inc. (NYSE:BKW-Free Report).
Ex-CEO charged in ballplayer's insider trade
AP - Wed Sep 24, 10:03PM CDT
SANTA ANA, Calif. (AP) — Federal prosecutors say the former CEO of a Southern California medical device company has been indicted on allegations that he shared insider trading secrets with former Baltimore Orioles All-Star Doug DeCinces.
Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
Swarup Gupta - Zacks Investment Research - Wed Sep 24, 9:22AM CDT
Late on Monday, the U.S. Treasury Department outlined new rules to deter domestic companies from moving abroad in an attempt to reduce tax payments.
Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.
PR Newswire - Wed Sep 24, 8:00AM CDT
Abbott today announced the expiration of the tender offer for the purchase from U.S. holders of the ordinary shares of CFR Pharmaceuticals S.A., a Chilean corporation, and for the purchase from all holders, wherever resident, of CFR's outstanding American Depositary Shares. The offer was not conditioned on the receipt of any minimum number of ordinary shares or American Depositary Shares being tendered.
Medical Diagnostic Devices Research Digest - H1 2014: Latest News for Medical Devices, In-Vitro Diagnostic Devices & Medical Imaging Devices
M2 - Wed Sep 24, 6:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnbznw/medical) has announced the addition of the "Medical Diagnostic Devices Research Digest - H1 2014" subscription to their offering. The Medical Diagnostic Devices Research Digest is a round-up of all the most important research in the industry each quarter available as an annual subscription, gathered from over 50 sources including associations, market intelligence companies, Journals, company news articles , consultants and industry participants. Updated quarterly, the Digest allows you to: - Quickly update yourself on the latest research findings, gathered and organised for you. - Get our Expert Analysts' perspectives on the latest research. - Link through to the original research to review or purchase. Key Topics Covered: 1 Global Medical Devices Research - Medical Devices M&A Value Falls by Over Half in 2013 Against 2012 - Global Medical Devices Market Showing Only Moderate Growth - Big Fall In Regulatory Approvals of Medical Devices - Top 10 Medical Device Companies 2013 - Cyber-Attacks on Medical Devices Endanger Patients' Lives - US Medical Device Manufacturers Paid $1bn in Excise Tax In 2013 - Strategic Rationale of Medtronic-Covidien Deal - Manufacturing Costs Of Medical Devices Significantly Lower Outside The U.S. - New Trends in Private Healthcare Service Providers in APAC, But Hospitals Remain the Major Providers - China's Healthcare Reform Continues to Drive Its Medical Devices Market 2 In Vitro Diagnostic Devices Research - Global In Vitro Diagnostic (IVD) Devices Market Moderate Growth - Johnson & Johnson Divests Its IVD Business - Becton Dickinson Leads Global Flow Cytometry Market - Clinical Chemistry And Coagulation Tests Dominate North America IVD Market - Cost Of Cholesterol Tests Vary Widely Across The U.S. - Molecular Diagnostics' Rapid Growth In The U.S. IVD Market - U.S. Companion Diagnostics Significant Growth - Hospital-Acquired Infections (HAI) Drive The U.S. Infectious Diseases Testing Market - U.S. IVD Market, Competitive Landscape 2013 - New Entrants Gain Share In The U.S. Blood Testing Market - European Companion Diagnostics' Remarkable Growth - European Law Restricts German IVD Market Growth - French IVD Market Restraints - French Government Strengthens Transparency In Healthcare Sector - Public Healthcare Budget Impacts On Italian IVD Market - Spanish IVD Market Declines Substantially - Nail Test For Bone Quality Launched In The UK - Taxes In Brazil Suppress IVD Market Growth - Brazilian IVD Manufacturers Gain Momentum - Rapid Growth Forecast For Chinese Digital Pathology Market - Public-Private Partnerships Drives Indian IVD Market - Indian IVD Market - Competitive Landscape - Indian Clinical Laboratories Still Use Manual Methods 3 Medical Imaging Devices Research - Diagnostic Ultrasound Market In Developed Economies Depends On Replacement Of Already Installed Systems - Film-Screen Mammography (FSM) Systems Usage Phased Out In Europe - Adoption Of Breast Tomosynthesis System Faster In Europe Than The U.S. - Prices Of CT And MRI Scan Vary Widely Across The U.S. - Medical Imaging Contribution To Washington State's Economy - Mammography Reduces U.S. Mortality Rate - Canadian Initiative Controls Overutilization Of Lumbar MRI Scans - China's Diagnostic X-Ray Imaging Market Sees Rapid Growth Companies Mentioned - Abbott - Abbott Laboratories - Agappe Diagnostics - Arkray - Beckman Coulter Inc. and Becton Dickinson - Bio-Rad and Danaher - CPC Diagnostics - Crescent Diagnostics - DASA Diagnostic Laboratory Group - EMD Millipore - GrupoFleury and Hermes Pardini - Hologic - Hologic - iCyt Sysmex - Johnson and Johnson - LabCorp - Lilac Medicare - Merck - Mindray - Ortho-Clinical Diagnostics - Partec - Qiagen - Quest Diagnostics - Roche Diagnostics - Siemens Healthcare - Sony Technology - Theranosis - Thermo fisher and Alere - Transasia Bio-Medicals - Tulip and Bhat-Biotech For more information visit http://www.researchandmarkets.com/research/rnbznw/medical
New Developments in the Companion Diagnostics Market 2014
M2 - Wed Sep 24, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zlp33x/companion) has announced the addition of the "Companion Diagnostics Market" report to their offering. There had been a slow market uptake of companion diagnostics because companion tests lacked FDA approval, which prevented pharmaceutical companies from promoting the diagnostic. But the realization that companion diagnostics can decrease costs by identifying the patient population that will most likely benefit from a therapy and ruling out those therapies not likely to be effective has made companion diagnostics important to the delivery of care. This report, Companion Diagnostics Markets tracks these new developments and focuses on companion diagnostics in medicine in 2013 and 2014. The report provides product analysis for the five broad areas of medical companion diagnostics and market information: Cancer Cardiovascular and Blood Metabolic Infection Neurological Market Size by Disease Area, 2013 and 2018Companion diagnostics have met with considerable challenges in penetrating the market, but are now rising to the forefront of pharmaceutical development and treatment, increasing the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. Companion diagnostics and biomarkers provide insight into understanding disease processes and ways that medicines can work to counteract the disease. The majority of competitive participation for companion diagnostics is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. There are numerous companies in the market which include large multiproduct companies such as Roche and Abbott and small niche developers such as 20/20 GeneSystems. Key Topics Covered: ONE: EXECUTIVE SUMMARY TWO: INTRODUCTION TO THE COMPANION DIAGNOSTICS INDUSTRY THREE: INDUSTRY TRENDS FOUR: COMPANION DIAGNOSTIC PRODUCTS FIVE: MARKET SIZE AND GROWTH SIX: COMPANY PROFILES - 20/20 Genesystems, Inc. - Abbott Laboratories - Affymetrix - Asuragen, Inc. - Beckman Coulter, Inc - Becton, Dickinson - Biocartis S.A. - Biodesix, Inc. - Biomerieux Sa - Bioreference Laboratories, Inc - Biotheranostics, Inc. - Cardiodx, Inc - Celera Alameda - Clarient, Inc - Decode Genetics, Inc. - Diagenic Asa - Genomic Health, Inc. - Genoptix Medical Laboratory - Illumina, Inc. - Johnson & Johnson - Life Technologies Corporation (Part Of Thermo Fisher) - Myriad Genetics, Inc. - Nanostring Technologies, Inc. - Opko Health, Inc. - Provista Dx - Qiagen N.V. - Roche - Siemens Healthcare - Singulex, Inc - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/zlp33x/companion
After Yesterday's Decline of 2.09%, Abbott Laboratories Offers Investors Better Value
Comtex SmarTrend(R) - Tue Sep 23, 3:53PM CDT
Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $42.49 to a high of $43.16. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $43.22 on volume of 6.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Abbott Laboratories Shares Up 10.8% Since SmarTrend's Buy Recommendation (ABT)
Comtex SmarTrend(R) - Tue Sep 23, 9:46AM CDT
SmarTrend identified an Uptrend for Abbott Laboratories (NYSE:ABT) on April 22nd, 2014 at $38.75. In approximately 5 months, Abbott Laboratories has returned 10.83% as of today's recent price of $42.94.
Research and Markets: China POCT Market 2014-2018: Abbott Laboratories, Bayer HealthCare, F. Hoffmann-La Roche & LifeScan Dominates the Market
Business Wire - Tue Sep 23, 3:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r3shd9/poct_market_in) has announced the addition of the "POCT Market in China 2014-2018" report to their offering.
China POCT Market 2014-2018: Abbott Laboratories, Bayer HealthCare, F. Hoffmann-La Roche & LifeScan Dominates the Market
M2 - Tue Sep 23, 3:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gch85q/poct_market_in) has announced the addition of the "POCT Market in China 2014-2018" report to their offering. The POCT market in China to grow at a CAGR of 20.69% over the period 2013-2018 POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. The expanding economy of China is one of the major trends witnessed in this market. The Government of China is making efforts to improve healthcare infrastructures, which has benefited the POCT market. According to the report, one of the major drivers in the market is the increase in innovations in technology to provide efficient and inexpensive devices to diagnose and treat diseases. Advances in technology and innovations in the Healthcare industry have resulted in the development of equipment with technology that is customized as per the needs of the patient. Further, the report states that one of the major challenges in the market is the advances in technology. The entry of new technology in the market forces the frequent elimination of the POCT products of the large vendors. To calculate the market size, the report considers the revenue generated through the following applications of POCT: - Blood glucose testing - Cholesterol testing - Infectious disease testing - Blood gas testing - Cardiac biomarkers testing - Pregnancy testing - Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing) Key Vendors - Abbott Laboratories - Bayer HealthCare - F. Hoffmann-La Roche - LifeScan Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Market Segmentation by Technology - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape For more information visit http://www.researchandmarkets.com/research/gc..._market_in
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 5:20PM CDT
Novo Nordisk (NVO) announced data from new analyses of the phase IIIa DUAL I and DUAL II studies on Xultophy.
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 3:45PM CDT
Novartis (NVS) announced that positive data on its pipeline candidate, LBH589 (panobinostat), was published in The Lancet Oncology.
Research and Markets: Global PCR Technologies Global Market 2014-2020
Business Wire - Mon Sep 22, 3:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rb5tts/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering.
Global PCR Technologies Global Market 2014-2020
M2 - Mon Sep 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4kvrrv/pcr_technologies) has announced the addition of the "PCR Technologies Global market - Forecast to 2020" report to their offering. Some of the key players in the PCR market are Abbott Laboratories, Affymetrix, inc., Takara bio, Agilent Technologies, Beckman Coulter Inc., Quanta biosciences, Bio-Rad, Becton, Dickinson and Co., GE Healthcare, Sigma-Aldrich Corp., and Roche. Polymerase chain reaction (PCR) is a gene amplification technique that amplifies a single or a few copies of a piece of DNA across several orders of magnitude, generating thousands to millions of copies of a particular DNA sequence. PCR plays a crucial role in understanding the genetic diseases and is also used in the characterization and detection of infectious disease organisms in diseases like Lyme disease, AIDS, middle ear infection and tuberculosis. PCR is an indispensable technique in Biotechnology, drug discovery and clinical diagnostics and it's key applications include DNA sequencing, Forensic science, Genotyping, Bioinformatics, gene expression, genetic mapping and DNA cloning. PCR products market includes Reagents, consumables, instruments, software and services. Some of the key techniques available in market are Standard/basic PCR, Real-time/Q-PCR, Digital PCR (dPCR), Reverse transcriptase PCR, Assembly PCR, Inverse PCR, Nested PCR, Multiplex PCR, Hot start PCR and touchdown PCR Among the various techniques, Q-PCR appears to be the fastest growing in PCR market followed by Reverse-Transcription PCR (RT-PCR) and Assembly. Based on the classification by products/tools, PCR Reagents is expected to be fastest growing PCR market followed by PCR Consumables and Machines. The global PCR market is projected to grow at a healthy rate. North America would account for the largest market share followed by Europe and Asia-pacific. Increasing number of patients suffering from Infectious diseases, Cancers and positive investments in gene therapy and human genome project are further driving the growth of the PCR market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 PCR Market by Types 5 PCR Market by Application 6 PCR Market by Technology 7 Regional Market Analysis 8 Company Developments 9 Major Company Profiles - Abbott Laboratories - Becton, Dickinson And Co. - Bio-Rad - Ge Healthcare - Kapa Biosystems - Maxim Biotech - Promega Corp. - Quanta Biosciences Inc. - Roche - Sigma-Aldrich Corp. - Takara Bio - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/4k...chnologies
(0)
(0)
